Literature DB >> 1487310

Selective enhancement of interleukin 1 beta production in myelomonocytic cell lines by insulin and its related cytokines.

V Holán1, J Minowada.   

Abstract

The production of interleukin 1 (IL-1) by lipopolysaccharide (LPS)-stimulated myelomonocytic cell lines ML-1, THP-1 and PL-21 was significantly enhanced by the addition of insulin, insulin-like growth factor (IGF)-I or IGF-II into the cell cultures. The IL-1 activity in the supernatants from cell cultures stimulated with LPS and insulin was completely neutralized by anti-IL-1 beta antibody. Anti-IL-1 alpha antibody had no inhibitory effect. Insulin itself did not stimulate IL-1 beta production directly, but increased it in the mitogen activated cells. However, insulin had no enhancing effect on the production of IL-1 alpha by human T cell lymphotropic virus-I (HTLV-I)-infected T cell lines or on IL-2 production by mitogen-stimulated leukemia T cell lines. Thus, insulin and its related cytokines are shown here as other molecules selectively modulating the production of IL-1 beta in myelomonocytic cell lines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487310     DOI: 10.1016/0165-2478(92)90220-i

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis.

Authors:  Julia Baumgartl; Stephanie Baudler; Maximilian Scherner; Vladimir Babaev; Liza Makowski; Jill Suttles; Marcia McDuffie; Kazuyuki Tobe; Takashi Kadowaki; Sergio Fazio; C Ronald Kahn; Gökhan S Hotamisligil; Wilhelm Krone; Macrae Linton; Jens C Brüning
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

Review 2.  Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.

Authors:  Ronan Thibaut; Matthew C Gage; Inès Pineda-Torra; Gwladys Chabrier; Nicolas Venteclef; Fawaz Alzaid
Journal:  FEBS J       Date:  2021-05-02       Impact factor: 5.622

3.  Increased body mass index is a risk factor for acute promyelocytic leukemia.

Authors:  Sarah M Kashanian; Andrew Y Li; Moaath Mustafa Ali; Mark E Sutherland; Vu H Duong; Bryan C Hambley; Kyle Zacholski; Firas El Chaer; Noa G Holtzman; Mohammad Imran; Ciera L Patzke; Jonathan Cornu; Alison Duffy; Amy E Dezern; Ivana Gojo; Kelly J Norsworthy; Mark J Levis; B Douglas Smith; Maria R Baer; Gabriel Ghiaur; Ashkan Emadi
Journal:  EJHaem       Date:  2021-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.